Quinazoline potassium channel inhibitors

Details for Australian Patent Application No. 2004275718 (hide)

Owner Merck & Co., Inc.

Inventors Trotter, B. Wesley; Isaacs, Richard

Agent Spruson & Ferguson

Pub. Number AU-B-2004275718

PCT Pub. Number WO2005/030217

Priority 60/505,139 23.09.03 US

Filing date 17 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 7 February 2008

International Classifications

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/90 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/96 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/030217 Priority application(s): WO2005/030217

7 February 2008 Application Accepted

  Published as AU-B-2004275718

5 June 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275719-Quinoline potassium channel inhibitors

2004275713-Conditioning composition comprising aminosilicone